Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 708

1.

'Seronegative antiphospholipid syndrome': an update.

Hughes GRV, Khamashta MA.

Lupus. 2019 Mar;28(3):273-274. doi: 10.1177/0961203319826358. Epub 2019 Jan 28. No abstract available.

PMID:
30691344
2.

Discovery of Small Molecule WWP2 Ubiquitin Ligase Inhibitors.

Watt JE, Hughes GR, Walpole S, Monaco S, Stephenson GR, Bulman Page PC, Hemmings AM, Angulo J, Chantry A.

Chemistry. 2018 Dec 3;24(67):17677-17680. doi: 10.1002/chem.201804169. Epub 2018 Nov 6.

PMID:
30207403
3.

Biological therapies in lupus.

Hughes GR.

Lupus. 2016 Sep;25(10):1069. doi: 10.1177/0961203316652949. No abstract available.

PMID:
27497250
4.

Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?

Noureldine MHA, Haydar AA, Berjawi A, Elnawar R, Sweid A, Khamashta MA, Hughes GRV, Uthman I.

Immunol Res. 2017 Feb;65(1):230-241. doi: 10.1007/s12026-016-8831-9. Review.

PMID:
27423434
5.

Musculoskeletal manifestations of the antiphospholipid syndrome.

Noureldine MH, Khamashta MA, Merashli M, Sabbouh T, Hughes GR, Uthman I.

Lupus. 2016 Apr;25(5):451-62. doi: 10.1177/0961203316636467. Epub 2016 Feb 27. Review.

PMID:
26923284
6.

LUPUS - 25 years old.

Hughes GR.

Lupus. 2016 Feb;25(2):115. doi: 10.1177/0961203315625461. No abstract available.

PMID:
26762644
7.

Multiple Oleomas Presenting as Dermatomyositis.

Zarroug J, Hughes GR, Edwards CJ.

Isr Med Assoc J. 2015 Oct;17(10):644-5. No abstract available.

8.

Lupus around the world.

Hughes GR.

Lupus. 2015 Aug;24(9):897-9. doi: 10.1177/0961203315587961. Epub 2015 Jun 4. No abstract available.

PMID:
26043954
9.

Hughes syndrome and multiple sclerosis.

Uthman I, Noureldine MH, Berjawi A, Skaf M, Haydar AA, Merashli M, Hughes GR.

Lupus. 2015 Feb;24(2):115-21. doi: 10.1177/0961203314555539. Epub 2014 Oct 17. Review.

PMID:
25326228
10.

Foreward. Inaccurately named antiphospholipid antibodies (aPL).

Hughes GR.

Lupus. 2014 Oct;23(12):1225. doi: 10.1177/0961203314549793. No abstract available.

PMID:
25228710
11.
12.

Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospholipid (Hughes) syndrome (APS).

Schofield JR, Blitshteyn S, Shoenfeld Y, Hughes GR.

Lupus. 2014 Jun;23(7):697-702. doi: 10.1177/0961203314524468. Epub 2014 Feb 25.

PMID:
24569396
13.

Are coastal protected areas always effective in achieving population recovery for nesting sea turtles?

Nel R, Punt AE, Hughes GR.

PLoS One. 2013 May 3;8(5):e63525. doi: 10.1371/journal.pone.0063525. Print 2013.

14.

Heparin, antiphospholipid antibodies and the brain.

Hughes GR.

Lupus. 2012 Sep;21(10):1039-40. doi: 10.1177/0961203312451336. Epub 2012 Jul 3. No abstract available.

PMID:
22759860
15.

Antiphospholipid antibody testing - slow progress?

Hughes GR, Shoenfeld Y.

Int J Clin Pract. 2012 Jun;66(6):533-5. doi: 10.1111/j.1742-1241.2011.02887.x. No abstract available.

PMID:
22607504
16.

Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome.

Conti F, Alessandri C, Sorice M, Capozzi A, Longo A, Garofalo T, Misasi R, Bompane D, Hughes GR, Khamashta MA, Valesini G.

Clin Exp Immunol. 2012 Mar;167(3):429-37. doi: 10.1111/j.1365-2249.2011.04532.x.

17.

The spectrum of ASIA: 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants'.

Agmon-Levin N, Hughes GR, Shoenfeld Y.

Lupus. 2012 Feb;21(2):118-20. doi: 10.1177/0961203311429316. No abstract available.

PMID:
22235040
18.

Anti-DNA activity in systemic lupus erythematosus.

Hughes GR, Cohen SA, Christian C.

Isr Med Assoc J. 2011 May;13(5):273. No abstract available.

19.

An important role for secreted esterase in disease establishment of the wheat powdery mildew fungus Blumeria graminis f. sp. tritici.

Feng J, Wang F, Hughes GR, Kaminskyj S, Wei Y.

Can J Microbiol. 2011 Mar;57(3):211-6. doi: 10.1139/W10-120.

PMID:
21358762
20.

Analysis of the promoter region of the gene LIP1 encoding triglyceride lipase from Fusarium graminearum.

Feng J, Bhadauria V, Liu G, Selvaraj G, Hughes GR, Wei Y.

Microbiol Res. 2011 Dec 20;166(8):618-28. doi: 10.1016/j.micres.2010.12.002. Epub 2011 Feb 3.

21.

Miscarriage and heart attack.

Hughes GR.

Lupus. 2011 Jan;20(1):3-4. doi: 10.1177/0961203310396020. No abstract available.

PMID:
21233147
22.

Hughes syndrome (the antiphospholipid syndrome): a disease of our time.

Hughes GR.

Inflammopharmacology. 2011 Apr;19(2):69-73. doi: 10.1007/s10787-010-0071-3. Epub 2010 Dec 5.

PMID:
21132565
23.

Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome.

Ortona E, Capozzi A, Colasanti T, Conti F, Alessandri C, Longo A, Garofalo T, Margutti P, Misasi R, Khamashta MA, Hughes GR, Valesini G, Sorice M.

Blood. 2010 Oct 21;116(16):2960-7. doi: 10.1182/blood-2010-04-279208. Epub 2010 Jul 15.

PMID:
20634382
24.

Feng Pao Hsii Lecture: Ten topics 2008. Hughes syndrome: a disease of our time.

Hughes GR.

Int J Rheum Dis. 2009 Apr;12(1):2-4. doi: 10.1111/j.1756-185X.2009.01371.x. No abstract available.

PMID:
20374308
25.

Antiphospholipid syndrome (Hughes syndrome): 10 clinical topics.

Hughes GR.

Lupus. 2010 Apr;19(4):343-6. doi: 10.1177/0961203309360842.

PMID:
20353967
26.

Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study.

Pisoni CN, Brucato A, Ruffatti A, Espinosa G, Cervera R, Belmonte-Serrano M, Sánchez-Román J, García-Hernández FG, Tincani A, Bertero MT, Doria A, Hughes GR, Khamashta MA.

Arthritis Rheum. 2010 Apr;62(4):1147-52. doi: 10.1002/art.27350.

27.

Antiphospholipid syndrome, migraine and stroke.

Hughes GR.

Lupus. 2010 Apr;19(5):555-6. doi: 10.1177/0961203309358186. Epub 2010 Jan 21. No abstract available.

PMID:
20093324
28.

Analysis of a Blumeria graminis-secreted lipase reveals the importance of host epicuticular wax components for fungal adhesion and development.

Feng J, Wang F, Liu G, Greenshields D, Shen W, Kaminskyj S, Hughes GR, Peng Y, Selvaraj G, Zou J, Wei Y.

Mol Plant Microbe Interact. 2009 Dec;22(12):1601-10. doi: 10.1094/MPMI-22-12-1601.

29.

Psychosis and catatonia as a first presentation of antiphospholipid syndrome.

Cardinal RN, Shah DN, Edwards CJ, Hughes GR, Fernández-Egea E.

Br J Psychiatry. 2009 Sep;195(3):272. doi: 10.1192/bjp.195.3.272. No abstract available.

PMID:
19721128
30.

The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe.

Cervera R, Boffa MC, Khamashta MA, Hughes GR.

Lupus. 2009 Sep;18(10):889-93. doi: 10.1177/0961203309106832.

PMID:
19671788
31.

The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe.

Cervera R, Khamashta MA, Hughes GR.

Lupus. 2009 Sep;18(10):869-74. doi: 10.1177/0961203309106831.

PMID:
19671784
32.

Clinical improvement in antiphospholipid syndrome after rituximab therapy.

Adamson R, Sangle S, Kaul A, Hughes GR, D'Cruz DP.

J Clin Rheumatol. 2008 Dec;14(6):359-60. doi: 10.1097/RHU.0b013e31818f38d4. No abstract available.

PMID:
19033874
33.

Genetic analysis of resistance to Pyrenophora tritici-repentis races 1 and 5 in tetraploid and hexaploid wheat.

Singh PK, Mergoum M, Ali S, Adhikari TB, Hughes GR.

Phytopathology. 2008 Jun;98(6):702-8. doi: 10.1094/PHYTO-98-6-0702.

34.
35.

Identification and Molecular Mapping of a Gene Conferring Resistance to Pyrenophora tritici-repentis Race 3 in Tetraploid Wheat.

Singh PK, Gonzalez-Hernandez JL, Mergoum M, Ali S, Adhikari TB, Kianian SF, Elias EM, Hughes GR.

Phytopathology. 2006 Aug;96(8):885-9. doi: 10.1094/PHYTO-96-0885.

36.

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients.

Cervera R, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Kiss E, Zeher MM, Tincani A, Kontopoulou-Griva I, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Roch B, Fernández-Nebro A, Piette JC, Espinosa G, Bucciarelli S, Pisoni CN, Bertolaccini ML, Boffa MC, Hughes GR; Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies).

Ann Rheum Dis. 2009 Sep;68(9):1428-32. doi: 10.1136/ard.2008.093179. Epub 2008 Sep 18.

PMID:
18801761
37.

Oxidation of LDL and its clinical implication.

Matsuura E, Hughes GR, Khamashta MA.

Autoimmun Rev. 2008 Jul;7(7):558-66. doi: 10.1016/j.autrev.2008.04.018. Epub 2008 May 12. Review.

PMID:
18625445
38.

Migraine and antiphospholipid antibodies: no association found in migraine-discordant monozygotic twins.

Williams FM, Cherkas LF, Bertolaccini ML, Murru V, Surdulescu GL, Hughes GR, Khamashta MA, Spector TD, MacGregor AJ.

Cephalalgia. 2008 Oct;28(10):1048-52. doi: 10.1111/j.1468-2982.2008.01646.x. Epub 2008 Jul 9.

PMID:
18624800
39.

Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis.

Sangle SR, Davies RJ, Mora M, Baron MA, Hughes GR, D'Cruz DP.

Rheumatology (Oxford). 2008 Jul;47(7):1058-60. doi: 10.1093/rheumatology/ken155. Epub 2008 May 22.

PMID:
18499719
40.

Hughes syndrome (the antiphospholipid syndrome): 25 years old.

Edwards CJ, Hughes GR.

Mod Rheumatol. 2008;18(2):119-24. doi: 10.1007/s10165-008-0042-3. Epub 2008 Mar 4. Review.

PMID:
18317878
41.

The point prevalence of an abnormal ankle-brachial index in antiphospholipid antibody negative patients with livedo reticularis: a controlled study.

Sangle S, Christodoulou C, Paul S, Hughes GR, D'Cruz DP.

Ann Rheum Dis. 2008 Feb;67(2):276-7. doi: 10.1136/ard.2007.074567. No abstract available.

PMID:
18192306
42.

Hughes Syndrome (the antiphospholipid syndrome): ten clinical lessons.

Hughes GR.

Autoimmun Rev. 2008 Jan;7(3):262-6. doi: 10.1016/j.autrev.2007.11.017. Epub 2007 Dec 7. Review.

PMID:
18190889
43.

Infliximab in patients with systemic vasculitis that is difficult to treat: poor outcome and significant adverse effects.

Sangle SR, Hughes GR, D'Cruz DP.

Ann Rheum Dis. 2007 Apr;66(4):564-5. No abstract available.

44.

Systemic lupus erythematosus.

D'Cruz DP, Khamashta MA, Hughes GR.

Lancet. 2007 Feb 17;369(9561):587-96. Review.

PMID:
17307106
45.

Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus.

Bertolaccini ML, Mepani K, Sanna G, Hughes GR, Khamashta MA.

Ann Rheum Dis. 2007 Apr;66(4):533-6. Epub 2006 Oct 4.

46.

Mycophenolate mofetil treatment in resistant myositis.

Pisoni CN, Cuadrado MJ, Khamashta MA, Hughes GR, D'Cruz DP.

Rheumatology (Oxford). 2007 Mar;46(3):516-8. Epub 2006 Sep 26.

PMID:
17003173
47.

Treatment of mesenteric angina with prolonged anticoagulation in a patient with antiphospholipid (Hughes) syndrome and coeliac artery stenosis.

Rosenthal E, Sangle SR, Taylor P, Khamashta MA, Hughes GR, D'Cruz DP.

Ann Rheum Dis. 2006 Oct;65(10):1398-9. No abstract available.

48.

Diagnosis of antiphospholipid syndrome.

Bertolaccini ML, Khamashta MA, Hughes GR.

Nat Clin Pract Rheumatol. 2005 Nov;1(1):40-6. Review.

PMID:
16932626
49.

Antiphospholipid antibody testing: which are most useful for diagnosis?

Bertolaccini ML, Hughes GR.

Rheum Dis Clin North Am. 2006 Aug;32(3):455-63. Review.

PMID:
16880078
50.

Coeliac artery stenosis and antiphospholipid (Hughes) syndrome/antiphospholipid anti-bodies.

Sangle SR, Jan W, Lau IS, Bennett AN, Hughes GR, D'Cruz DP.

Clin Exp Rheumatol. 2006 May-Jun;24(3):349. No abstract available.

PMID:
16870110

Supplemental Content

Loading ...
Support Center